Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID-19
Complement, a critical defence against pathogens, has been implicated as a driver of pathology in COVID-19. Complement activation products are detected in plasma and tissues and complement blockade considered for therapy. To delineate roles of complement in immunopathogenesis, we undertook the large...
Hlavní autoři: | Siggins, M, Davies, K, Fellows, R, Thwaites, R, Baillie, K, Semple, M, Openshaw, P, Zelek, W, Harris, CL, Morgan, BP, Dunning, W |
---|---|
Další autoři: | The ISARIC4C Investigators |
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Wiley
2022
|
Podobné jednotky
-
Dysregulation of complement system in HELLP syndrome
Autor: Shi Chen, a další
Vydáno: (2021-10-01) -
Terminal complement pathway activation drives synaptic loss in Alzheimer’s disease models
Autor: Sarah M. Carpanini, a další
Vydáno: (2022-07-01) -
Measuring Total Classical Pathway and Activities of Individual Components of the Mouse Complement Pathway
Autor: Wioleta Zelek
Vydáno: (2021-10-01) -
Seasonal and pandemic influenza: 100 years of progress, still much to learn
Autor: Dunning, WJ, a další
Vydáno: (2020) -
Complement dysregulation is associated with severe COVID-19 illness
Autor: Jia Yu, a další
Vydáno: (2021-07-01)